While kuttu atta is one of the most popular flours consumed during a Navratri fast, it is not the only option. You can also ...

In May 2023, the World Health Organization ( WHO) recommended against using non-sugar sweeteners like sucralose for weight ...

Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone wrong?

When it come to training with free weights or machines, rarely has the fitness world been so divided. On one side, you’ve got the purists who swear by barbells, dumbbells, and kettlebells.

(Reuters) -Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 billion in global sales since its initial U.S. launch in 2022.

Eli Lilly has launched its blockbuster weight loss drug, Mounjaro, in India, offering a novel treatment for obesity and type 2 diabetes. This first-of-its-kind drug activates both GIP and GLP-1 ...

Here are the top stories to read during Wednesday's trading: ...

USA Politics icons set #08 Specification: 30 icons, 64×64 pх, EDITABLE stroke weight! Current stroke 2 px. Features: Pixel Perfect, Unicolor, Editable weight thin line. First row of icons contains: ...

Can Nvidia Corp.’s “brutalized” stock meaningfully turn things around? Shares of Nvidia — and Broadcom Inc., for that matter — “are looking attractive for those who can wait out the ...

Roche (OTCQX:RHHBY) is looking to boost its presence in the booming weight-loss market through an exclusive collaboration and licensing deal with Danish biotech Zealand Pharma (OTCPK:ZLDPF).

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...